UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Renal Mass and Localized Renal Cancer: AUA Guideline

The Journal of urology, 2017-09, Vol.198 (3), p.520-529

2017

Volltextzugriff (PDF)

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network, 2022-01, Vol.20 (1), p.71-90

2022

Volltextzugriff (PDF)

Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate

European urology, 2015-12, Vol.68 (6), p.996-1003

2015

Volltextzugriff (PDF)

Chronic Kidney Disease Due to Surgical Removal of Nephrons: Relative Rates of Progression and Survival

The Journal of urology, 2014-10, Vol.192 (4), p.1057-1063

2014

Volltextzugriff (PDF)

Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline

The Journal of urology, 2013-08, Vol.190 (2), p.407-416

2013

Volltextzugriff (PDF)

Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives

International journal of urology, 2019-05, Vol.26 (5), p.532-542

2019

Volltextzugriff (PDF)

Neoadjuvant therapy for localized and locally advanced renal cell carcinoma

Urologic oncology, 2018-01, Vol.36 (1), p.31-37

2018

Volltextzugriff (PDF)

Chronic Kidney Disease Is More Common in Locally Advanced Renal Cell Carcinoma

Urology (Ridgewood, N.J.), 2017-07, Vol.105, p.101-107

2017

Volltextzugriff (PDF)

Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC)

Clinical genitourinary cancer, 2021-08, Vol.19 (4), p.e206-e215

2021

Volltextzugriff (PDF)

Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors

Current opinion in urology, 2014-09, Vol.24 (5), p.448-452

2014

Volltextzugriff (PDF)

Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy

BJU international, 2009-08, Vol.104 (4), p.476-481

2009

Volltextzugriff (PDF)

A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors

Asian Journal of Urology, 2023-10, Vol.10 (4), p.390-406

2023

Volltextzugriff (PDF)

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)

Frontiers in oncology, 2023-03, Vol.13, p.1113246-1113246

2023

Volltextzugriff (PDF)

Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center

Medicina (Kaunas, Lithuania), 2024-03, Vol.60 (3), p.463

2024

Volltextzugriff (PDF)

Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma

Urologic oncology, 2015-03, Vol.33 (3), p.112.e15-112.e21

2015

Volltextzugriff (PDF)

Split Renal Function Is Fundamentally Important for Predicting Functional Recovery After Radical Nephrectomy

European urology open science (Online), 2022-06, Vol.40, p.112-116

2022

Volltextzugriff (PDF)

Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy

European urology open science (Online), 2024-05, Vol.63, p.71-80

2024

Volltextzugriff (PDF)

Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy

BJUI compass, 2024-10, Vol.5 (10), p.942-949

2024

Volltextzugriff (PDF)

Primary Cytoreductive Nephrectomy: Standing the Test of Time?

European urology, 2023-02, Vol.83 (2), p.152-153

2023

Volltextzugriff (PDF)

Comparison of Laparoendoscopic Single-site and Multiport Laparoscopic Radical and Partial Nephrectomy: A Prospective, Nonrandomized Study

Urology (Ridgewood, N.J.), 2012-11, Vol.80 (5), p.1039-1045

2012

Volltextzugriff (PDF)

Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma

BJU international, 2016-12, Vol.118 (6), p.927-934

2016

Volltextzugriff (PDF)

Guideline for Management of the Clinical T1 Renal Mass

The Journal of urology, 2009-10, Vol.182 (4), p.1271-1279

2009

Volltextzugriff (PDF)

NCCN Guidelines Insights: Kidney Cancer, Version 2.2020

Journal of the National Comprehensive Cancer Network, 2019-11, Vol.17 (11), p.1278-1285

2019

Volltextzugriff (PDF)

Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network, 2019-12, Vol.17 (12), p.1529-1554

2019

Volltextzugriff (PDF)

Percutaneous Biopsy of Renal Masses—When is it Necessary?

The Journal of urology, 2016-03, Vol.195 (3), p.542-543

Derweesh, Ithaar H

2016

Volltextzugriff (PDF)

1 – 25 von 387

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(379)
Mit Volltextzugriff
(231)

Publikationsform

Sprache

Englisch
(387)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Renal Mass and Localized Renal Cancer: AUA Guideline

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate

Chronic Kidney Disease Due to Surgical Removal of Nephrons: Relative Rates of Progression and Survival

Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline

Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives

Neoadjuvant therapy for localized and locally advanced renal cell carcinoma

Chronic Kidney Disease Is More Common in Locally Advanced Renal Cell Carcinoma

Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC)

Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors

Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy

A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)

Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center

Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma

Split Renal Function Is Fundamentally Important for Predicting Functional Recovery After Radical Nephrectomy

Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy

Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy

Primary Cytoreductive Nephrectomy: Standing the Test of Time?

Comparison of Laparoendoscopic Single-site and Multiport Laparoscopic Radical and Partial Nephrectomy: A Prospective, Nonrandomized Study

Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma

Guideline for Management of the Clinical T1 Renal Mass

NCCN Guidelines Insights: Kidney Cancer, Version 2.2020

Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Percutaneous Biopsy of Renal Masses—When is it Necessary?

Suchergebnisse filtern